Medications used in dementia: a review of evidence psychological symptoms of dementia (BPSD), and has also being considered for the treatment of dementias of lesser severity.Evidence also supports the use of AChE inhibitors in vascular dementia and dementia due to Parkinson's disease (PDD). But evidence regarding efficacy in dementia of Lewy Body (DLB) is not very strong.Antipsychotics can be used for the management of BPSD if other measures fail, keeping in mind the black box warning for the risk of stroke. The use of antidepressants and mood stabilisers are limited by the lack of strong evidence. ConclusionThe current evidence supports the use of cholinesterase inhibitors and memantine in patients with Alzheimer's dementia, vascular dementia and PDD, with a positive impact on global assessment, cognitive function, behavioural disturbance and activities of daily living rating scales. The effect in DLB remains unclear. SL J Psychiatry 2015; 6(2): 3-8 BackgroundDementia is an acquired global impairment of intellect, memory and personality, without impairment of consciousness. It is usually progressive in nature. The management of dementia is mainly two faceted; pharmacological and non-pharmacological. AimsTo review the evidence regarding the efficacy of cholinesterase inhibitors, memantine and antipsychotics, in the treatment of dementia. MethodsWe searched ALOIS, Cochrane database, PubMed, Scopus and Google scholar using key words; dementia, cognitive enhancers, cholinesterase inhibitors and memantine as individual words for relevant review articles. ResultsThere is evidence of efficacy of donepezil, rivastigmine and galantamine in mild to moderate Alzheimer's dementia (AD). Evidence also suggests that memantine has efficacy in moderate to severe AD. Further, memantine may benefit behavioural and
We describe the case of a sixty-five year old male presenting with acting out his violent dreams over a period of twelve years, causing injury to himself and his spouse. His case was not conducive to sleep studies, and the diagnosis of idiopathic REM sleep
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.